Global Pharmacogenomics Services Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Pharmacogenomics Services market size was estimated at USD 1444.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmacogenomics Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmacogenomics Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmacogenomics Services market.
Global Pharmacogenomics Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Admera Health, LLC
Mesa Laboratories, Inc.
Dynamic DNA Laboratories
F. Hoffmann-La Roche Ltd.
GeneOmbio Technologies Pvt Ltd.
Exact Sciences Corporation
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
OmeCare
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Precipio
23andMe, Inc.
OneOme, LLC
DiaCarta, Inc.
OPKO Health
Market Segmentation (by Type)
Genotyping
SNP Identification
Pharmacogenetic Testing
Others
Market Segmentation (by Application)
Oncology
Infectious Diseases
Psychiatry
Cardiovascular
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pharmacogenomics Services Market
Overview of the regional outlook of the Pharmacogenomics Services Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacogenomics Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmacogenomics Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Pharmacogenomics Services market size was estimated at USD 1444.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmacogenomics Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmacogenomics Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmacogenomics Services market.
Global Pharmacogenomics Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Admera Health, LLC
Mesa Laboratories, Inc.
Dynamic DNA Laboratories
F. Hoffmann-La Roche Ltd.
GeneOmbio Technologies Pvt Ltd.
Exact Sciences Corporation
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
OmeCare
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Precipio
23andMe, Inc.
OneOme, LLC
DiaCarta, Inc.
OPKO Health
Market Segmentation (by Type)
Genotyping
SNP Identification
Pharmacogenetic Testing
Others
Market Segmentation (by Application)
Oncology
Infectious Diseases
Psychiatry
Cardiovascular
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pharmacogenomics Services Market
Overview of the regional outlook of the Pharmacogenomics Services Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacogenomics Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmacogenomics Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pharmacogenomics Services
1.2 Key Market Segments
1.2.1 Pharmacogenomics Services Segment by Type
1.2.2 Pharmacogenomics Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOGENOMICS SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacogenomics Services Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pharmacogenomics Services Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOGENOMICS SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pharmacogenomics Services Product Life Cycle
3.3 Global Pharmacogenomics Services Sales by Manufacturers (2020-2025)
3.4 Global Pharmacogenomics Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Pharmacogenomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pharmacogenomics Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pharmacogenomics Services Market Competitive Situation and Trends
3.8.1 Pharmacogenomics Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pharmacogenomics Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PHARMACOGENOMICS SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Pharmacogenomics Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOGENOMICS SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pharmacogenomics Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pharmacogenomics Services Market
5.7 ESG Ratings of Leading Companies
6 PHARMACOGENOMICS SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacogenomics Services Sales Market Share by Type (2020-2025)
6.3 Global Pharmacogenomics Services Market Size by Type (2020-2025)
6.4 Global Pharmacogenomics Services Price by Type (2020-2025)
7 PHARMACOGENOMICS SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacogenomics Services Market Sales by Application (2020-2025)
7.3 Global Pharmacogenomics Services Market Size (M USD) by Application (2020-2025)
7.4 Global Pharmacogenomics Services Sales Growth Rate by Application (2020-2025)
8 PHARMACOGENOMICS SERVICES MARKET SALES BY REGION
8.1 Global Pharmacogenomics Services Sales by Region
8.1.1 Global Pharmacogenomics Services Sales by Region
8.1.2 Global Pharmacogenomics Services Sales Market Share by Region
8.2 Global Pharmacogenomics Services Market Size by Region
8.2.1 Global Pharmacogenomics Services Market Size by Region
8.2.2 Global Pharmacogenomics Services Market Size by Region
8.3 North America
8.3.1 North America Pharmacogenomics Services Sales by Country
8.3.2 North America Pharmacogenomics Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pharmacogenomics Services Sales by Country
8.4.2 Europe Pharmacogenomics Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pharmacogenomics Services Sales by Region
8.5.2 Asia Pacific Pharmacogenomics Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pharmacogenomics Services Sales by Country
8.6.2 South America Pharmacogenomics Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pharmacogenomics Services Sales by Region
8.7.2 Middle East and Africa Pharmacogenomics Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PHARMACOGENOMICS SERVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Pharmacogenomics Services by Region(2020-2025)
9.2 Global Pharmacogenomics Services Revenue Market Share by Region (2020-2025)
9.3 Global Pharmacogenomics Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pharmacogenomics Services Production
9.4.1 North America Pharmacogenomics Services Production Growth Rate (2020-2025)
9.4.2 North America Pharmacogenomics Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pharmacogenomics Services Production
9.5.1 Europe Pharmacogenomics Services Production Growth Rate (2020-2025)
9.5.2 Europe Pharmacogenomics Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pharmacogenomics Services Production (2020-2025)
9.6.1 Japan Pharmacogenomics Services Production Growth Rate (2020-2025)
9.6.2 Japan Pharmacogenomics Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pharmacogenomics Services Production (2020-2025)
9.7.1 China Pharmacogenomics Services Production Growth Rate (2020-2025)
9.7.2 China Pharmacogenomics Services Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Pharmacogenomics Services Product Overview
10.1.3 Abbott Laboratories Pharmacogenomics Services Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Admera Health, LLC
10.2.1 Admera Health, LLC Basic Information
10.2.2 Admera Health, LLC Pharmacogenomics Services Product Overview
10.2.3 Admera Health, LLC Pharmacogenomics Services Product Market Performance
10.2.4 Admera Health, LLC Business Overview
10.2.5 Admera Health, LLC SWOT Analysis
10.2.6 Admera Health, LLC Recent Developments
10.3 Mesa Laboratories, Inc.
10.3.1 Mesa Laboratories, Inc. Basic Information
10.3.2 Mesa Laboratories, Inc. Pharmacogenomics Services Product Overview
10.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Product Market Performance
10.3.4 Mesa Laboratories, Inc. Business Overview
10.3.5 Mesa Laboratories, Inc. SWOT Analysis
10.3.6 Mesa Laboratories, Inc. Recent Developments
10.4 Dynamic DNA Laboratories
10.4.1 Dynamic DNA Laboratories Basic Information
10.4.2 Dynamic DNA Laboratories Pharmacogenomics Services Product Overview
10.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Product Market Performance
10.4.4 Dynamic DNA Laboratories Business Overview
10.4.5 Dynamic DNA Laboratories Recent Developments
10.5 F. Hoffmann-La Roche Ltd.
10.5.1 F. Hoffmann-La Roche Ltd. Basic Information
10.5.2 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Overview
10.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Market Performance
10.5.4 F. Hoffmann-La Roche Ltd. Business Overview
10.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.6 GeneOmbio Technologies Pvt Ltd.
10.6.1 GeneOmbio Technologies Pvt Ltd. Basic Information
10.6.2 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Overview
10.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Market Performance
10.6.4 GeneOmbio Technologies Pvt Ltd. Business Overview
10.6.5 GeneOmbio Technologies Pvt Ltd. Recent Developments
10.7 Exact Sciences Corporation
10.7.1 Exact Sciences Corporation Basic Information
10.7.2 Exact Sciences Corporation Pharmacogenomics Services Product Overview
10.7.3 Exact Sciences Corporation Pharmacogenomics Services Product Market Performance
10.7.4 Exact Sciences Corporation Business Overview
10.7.5 Exact Sciences Corporation Recent Developments
10.8 Illumina, Inc.
10.8.1 Illumina, Inc. Basic Information
10.8.2 Illumina, Inc. Pharmacogenomics Services Product Overview
10.8.3 Illumina, Inc. Pharmacogenomics Services Product Market Performance
10.8.4 Illumina, Inc. Business Overview
10.8.5 Illumina, Inc. Recent Developments
10.9 Laboratory Corporation of America Holdings
10.9.1 Laboratory Corporation of America Holdings Basic Information
10.9.2 Laboratory Corporation of America Holdings Pharmacogenomics Services Product Overview
10.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Product Market Performance
10.9.4 Laboratory Corporation of America Holdings Business Overview
10.9.5 Laboratory Corporation of America Holdings Recent Developments
10.10 Myriad Genetics, Inc.
10.10.1 Myriad Genetics, Inc. Basic Information
10.10.2 Myriad Genetics, Inc. Pharmacogenomics Services Product Overview
10.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Product Market Performance
10.10.4 Myriad Genetics, Inc. Business Overview
10.10.5 Myriad Genetics, Inc. Recent Developments
10.11 OmeCare
10.11.1 OmeCare Basic Information
10.11.2 OmeCare Pharmacogenomics Services Product Overview
10.11.3 OmeCare Pharmacogenomics Services Product Market Performance
10.11.4 OmeCare Business Overview
10.11.5 OmeCare Recent Developments
10.12 QIAGEN N.V.
10.12.1 QIAGEN N.V. Basic Information
10.12.2 QIAGEN N.V. Pharmacogenomics Services Product Overview
10.12.3 QIAGEN N.V. Pharmacogenomics Services Product Market Performance
10.12.4 QIAGEN N.V. Business Overview
10.12.5 QIAGEN N.V. Recent Developments
10.13 Quest Diagnostics Incorporated
10.13.1 Quest Diagnostics Incorporated Basic Information
10.13.2 Quest Diagnostics Incorporated Pharmacogenomics Services Product Overview
10.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Product Market Performance
10.13.4 Quest Diagnostics Incorporated Business Overview
10.13.5 Quest Diagnostics Incorporated Recent Developments
10.14 Thermo Fisher Scientific Inc.
10.14.1 Thermo Fisher Scientific Inc. Basic Information
10.14.2 Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Overview
10.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Market Performance
10.14.4 Thermo Fisher Scientific Inc. Business Overview
10.14.5 Thermo Fisher Scientific Inc. Recent Developments
10.15 Precipio
10.15.1 Precipio Basic Information
10.15.2 Precipio Pharmacogenomics Services Product Overview
10.15.3 Precipio Pharmacogenomics Services Product Market Performance
10.15.4 Precipio Business Overview
10.15.5 Precipio Recent Developments
10.16 23andMe, Inc.
10.16.1 23andMe, Inc. Basic Information
10.16.2 23andMe, Inc. Pharmacogenomics Services Product Overview
10.16.3 23andMe, Inc. Pharmacogenomics Services Product Market Performance
10.16.4 23andMe, Inc. Business Overview
10.16.5 23andMe, Inc. Recent Developments
10.17 OneOme, LLC
10.17.1 OneOme, LLC Basic Information
10.17.2 OneOme, LLC Pharmacogenomics Services Product Overview
10.17.3 OneOme, LLC Pharmacogenomics Services Product Market Performance
10.17.4 OneOme, LLC Business Overview
10.17.5 OneOme, LLC Recent Developments
10.18 DiaCarta, Inc.
10.18.1 DiaCarta, Inc. Basic Information
10.18.2 DiaCarta, Inc. Pharmacogenomics Services Product Overview
10.18.3 DiaCarta, Inc. Pharmacogenomics Services Product Market Performance
10.18.4 DiaCarta, Inc. Business Overview
10.18.5 DiaCarta, Inc. Recent Developments
10.19 OPKO Health
10.19.1 OPKO Health Basic Information
10.19.2 OPKO Health Pharmacogenomics Services Product Overview
10.19.3 OPKO Health Pharmacogenomics Services Product Market Performance
10.19.4 OPKO Health Business Overview
10.19.5 OPKO Health Recent Developments
11 PHARMACOGENOMICS SERVICES MARKET FORECAST BY REGION
11.1 Global Pharmacogenomics Services Market Size Forecast
11.2 Global Pharmacogenomics Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmacogenomics Services Market Size Forecast by Country
11.2.3 Asia Pacific Pharmacogenomics Services Market Size Forecast by Region
11.2.4 South America Pharmacogenomics Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pharmacogenomics Services by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pharmacogenomics Services Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pharmacogenomics Services by Type (2026-2035)
12.1.2 Global Pharmacogenomics Services Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pharmacogenomics Services by Type (2026-2035)
12.2 Global Pharmacogenomics Services Market Forecast by Application (2026-2035)
12.2.1 Global Pharmacogenomics Services Sales (K Units) Forecast by Application
12.2.2 Global Pharmacogenomics Services Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pharmacogenomics Services
1.2 Key Market Segments
1.2.1 Pharmacogenomics Services Segment by Type
1.2.2 Pharmacogenomics Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOGENOMICS SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacogenomics Services Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Pharmacogenomics Services Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOGENOMICS SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pharmacogenomics Services Product Life Cycle
3.3 Global Pharmacogenomics Services Sales by Manufacturers (2020-2025)
3.4 Global Pharmacogenomics Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Pharmacogenomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pharmacogenomics Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pharmacogenomics Services Market Competitive Situation and Trends
3.8.1 Pharmacogenomics Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pharmacogenomics Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PHARMACOGENOMICS SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Pharmacogenomics Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOGENOMICS SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pharmacogenomics Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pharmacogenomics Services Market
5.7 ESG Ratings of Leading Companies
6 PHARMACOGENOMICS SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacogenomics Services Sales Market Share by Type (2020-2025)
6.3 Global Pharmacogenomics Services Market Size by Type (2020-2025)
6.4 Global Pharmacogenomics Services Price by Type (2020-2025)
7 PHARMACOGENOMICS SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacogenomics Services Market Sales by Application (2020-2025)
7.3 Global Pharmacogenomics Services Market Size (M USD) by Application (2020-2025)
7.4 Global Pharmacogenomics Services Sales Growth Rate by Application (2020-2025)
8 PHARMACOGENOMICS SERVICES MARKET SALES BY REGION
8.1 Global Pharmacogenomics Services Sales by Region
8.1.1 Global Pharmacogenomics Services Sales by Region
8.1.2 Global Pharmacogenomics Services Sales Market Share by Region
8.2 Global Pharmacogenomics Services Market Size by Region
8.2.1 Global Pharmacogenomics Services Market Size by Region
8.2.2 Global Pharmacogenomics Services Market Size by Region
8.3 North America
8.3.1 North America Pharmacogenomics Services Sales by Country
8.3.2 North America Pharmacogenomics Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pharmacogenomics Services Sales by Country
8.4.2 Europe Pharmacogenomics Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pharmacogenomics Services Sales by Region
8.5.2 Asia Pacific Pharmacogenomics Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pharmacogenomics Services Sales by Country
8.6.2 South America Pharmacogenomics Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pharmacogenomics Services Sales by Region
8.7.2 Middle East and Africa Pharmacogenomics Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PHARMACOGENOMICS SERVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Pharmacogenomics Services by Region(2020-2025)
9.2 Global Pharmacogenomics Services Revenue Market Share by Region (2020-2025)
9.3 Global Pharmacogenomics Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pharmacogenomics Services Production
9.4.1 North America Pharmacogenomics Services Production Growth Rate (2020-2025)
9.4.2 North America Pharmacogenomics Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pharmacogenomics Services Production
9.5.1 Europe Pharmacogenomics Services Production Growth Rate (2020-2025)
9.5.2 Europe Pharmacogenomics Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pharmacogenomics Services Production (2020-2025)
9.6.1 Japan Pharmacogenomics Services Production Growth Rate (2020-2025)
9.6.2 Japan Pharmacogenomics Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pharmacogenomics Services Production (2020-2025)
9.7.1 China Pharmacogenomics Services Production Growth Rate (2020-2025)
9.7.2 China Pharmacogenomics Services Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Pharmacogenomics Services Product Overview
10.1.3 Abbott Laboratories Pharmacogenomics Services Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Admera Health, LLC
10.2.1 Admera Health, LLC Basic Information
10.2.2 Admera Health, LLC Pharmacogenomics Services Product Overview
10.2.3 Admera Health, LLC Pharmacogenomics Services Product Market Performance
10.2.4 Admera Health, LLC Business Overview
10.2.5 Admera Health, LLC SWOT Analysis
10.2.6 Admera Health, LLC Recent Developments
10.3 Mesa Laboratories, Inc.
10.3.1 Mesa Laboratories, Inc. Basic Information
10.3.2 Mesa Laboratories, Inc. Pharmacogenomics Services Product Overview
10.3.3 Mesa Laboratories, Inc. Pharmacogenomics Services Product Market Performance
10.3.4 Mesa Laboratories, Inc. Business Overview
10.3.5 Mesa Laboratories, Inc. SWOT Analysis
10.3.6 Mesa Laboratories, Inc. Recent Developments
10.4 Dynamic DNA Laboratories
10.4.1 Dynamic DNA Laboratories Basic Information
10.4.2 Dynamic DNA Laboratories Pharmacogenomics Services Product Overview
10.4.3 Dynamic DNA Laboratories Pharmacogenomics Services Product Market Performance
10.4.4 Dynamic DNA Laboratories Business Overview
10.4.5 Dynamic DNA Laboratories Recent Developments
10.5 F. Hoffmann-La Roche Ltd.
10.5.1 F. Hoffmann-La Roche Ltd. Basic Information
10.5.2 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Overview
10.5.3 F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Market Performance
10.5.4 F. Hoffmann-La Roche Ltd. Business Overview
10.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.6 GeneOmbio Technologies Pvt Ltd.
10.6.1 GeneOmbio Technologies Pvt Ltd. Basic Information
10.6.2 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Overview
10.6.3 GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Market Performance
10.6.4 GeneOmbio Technologies Pvt Ltd. Business Overview
10.6.5 GeneOmbio Technologies Pvt Ltd. Recent Developments
10.7 Exact Sciences Corporation
10.7.1 Exact Sciences Corporation Basic Information
10.7.2 Exact Sciences Corporation Pharmacogenomics Services Product Overview
10.7.3 Exact Sciences Corporation Pharmacogenomics Services Product Market Performance
10.7.4 Exact Sciences Corporation Business Overview
10.7.5 Exact Sciences Corporation Recent Developments
10.8 Illumina, Inc.
10.8.1 Illumina, Inc. Basic Information
10.8.2 Illumina, Inc. Pharmacogenomics Services Product Overview
10.8.3 Illumina, Inc. Pharmacogenomics Services Product Market Performance
10.8.4 Illumina, Inc. Business Overview
10.8.5 Illumina, Inc. Recent Developments
10.9 Laboratory Corporation of America Holdings
10.9.1 Laboratory Corporation of America Holdings Basic Information
10.9.2 Laboratory Corporation of America Holdings Pharmacogenomics Services Product Overview
10.9.3 Laboratory Corporation of America Holdings Pharmacogenomics Services Product Market Performance
10.9.4 Laboratory Corporation of America Holdings Business Overview
10.9.5 Laboratory Corporation of America Holdings Recent Developments
10.10 Myriad Genetics, Inc.
10.10.1 Myriad Genetics, Inc. Basic Information
10.10.2 Myriad Genetics, Inc. Pharmacogenomics Services Product Overview
10.10.3 Myriad Genetics, Inc. Pharmacogenomics Services Product Market Performance
10.10.4 Myriad Genetics, Inc. Business Overview
10.10.5 Myriad Genetics, Inc. Recent Developments
10.11 OmeCare
10.11.1 OmeCare Basic Information
10.11.2 OmeCare Pharmacogenomics Services Product Overview
10.11.3 OmeCare Pharmacogenomics Services Product Market Performance
10.11.4 OmeCare Business Overview
10.11.5 OmeCare Recent Developments
10.12 QIAGEN N.V.
10.12.1 QIAGEN N.V. Basic Information
10.12.2 QIAGEN N.V. Pharmacogenomics Services Product Overview
10.12.3 QIAGEN N.V. Pharmacogenomics Services Product Market Performance
10.12.4 QIAGEN N.V. Business Overview
10.12.5 QIAGEN N.V. Recent Developments
10.13 Quest Diagnostics Incorporated
10.13.1 Quest Diagnostics Incorporated Basic Information
10.13.2 Quest Diagnostics Incorporated Pharmacogenomics Services Product Overview
10.13.3 Quest Diagnostics Incorporated Pharmacogenomics Services Product Market Performance
10.13.4 Quest Diagnostics Incorporated Business Overview
10.13.5 Quest Diagnostics Incorporated Recent Developments
10.14 Thermo Fisher Scientific Inc.
10.14.1 Thermo Fisher Scientific Inc. Basic Information
10.14.2 Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Overview
10.14.3 Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Market Performance
10.14.4 Thermo Fisher Scientific Inc. Business Overview
10.14.5 Thermo Fisher Scientific Inc. Recent Developments
10.15 Precipio
10.15.1 Precipio Basic Information
10.15.2 Precipio Pharmacogenomics Services Product Overview
10.15.3 Precipio Pharmacogenomics Services Product Market Performance
10.15.4 Precipio Business Overview
10.15.5 Precipio Recent Developments
10.16 23andMe, Inc.
10.16.1 23andMe, Inc. Basic Information
10.16.2 23andMe, Inc. Pharmacogenomics Services Product Overview
10.16.3 23andMe, Inc. Pharmacogenomics Services Product Market Performance
10.16.4 23andMe, Inc. Business Overview
10.16.5 23andMe, Inc. Recent Developments
10.17 OneOme, LLC
10.17.1 OneOme, LLC Basic Information
10.17.2 OneOme, LLC Pharmacogenomics Services Product Overview
10.17.3 OneOme, LLC Pharmacogenomics Services Product Market Performance
10.17.4 OneOme, LLC Business Overview
10.17.5 OneOme, LLC Recent Developments
10.18 DiaCarta, Inc.
10.18.1 DiaCarta, Inc. Basic Information
10.18.2 DiaCarta, Inc. Pharmacogenomics Services Product Overview
10.18.3 DiaCarta, Inc. Pharmacogenomics Services Product Market Performance
10.18.4 DiaCarta, Inc. Business Overview
10.18.5 DiaCarta, Inc. Recent Developments
10.19 OPKO Health
10.19.1 OPKO Health Basic Information
10.19.2 OPKO Health Pharmacogenomics Services Product Overview
10.19.3 OPKO Health Pharmacogenomics Services Product Market Performance
10.19.4 OPKO Health Business Overview
10.19.5 OPKO Health Recent Developments
11 PHARMACOGENOMICS SERVICES MARKET FORECAST BY REGION
11.1 Global Pharmacogenomics Services Market Size Forecast
11.2 Global Pharmacogenomics Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmacogenomics Services Market Size Forecast by Country
11.2.3 Asia Pacific Pharmacogenomics Services Market Size Forecast by Region
11.2.4 South America Pharmacogenomics Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pharmacogenomics Services by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Pharmacogenomics Services Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Pharmacogenomics Services by Type (2026-2035)
12.1.2 Global Pharmacogenomics Services Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Pharmacogenomics Services by Type (2026-2035)
12.2 Global Pharmacogenomics Services Market Forecast by Application (2026-2035)
12.2.1 Global Pharmacogenomics Services Sales (K Units) Forecast by Application
12.2.2 Global Pharmacogenomics Services Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pharmacogenomics Services Market Size by Type (M USD)
Table 4. Global Pharmacogenomics Services Market Size by Application
Table 5. Pharmacogenomics Services Market Size Comparison by Region (M USD)
Table 6. Global Pharmacogenomics Services Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Pharmacogenomics Services Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pharmacogenomics Services Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pharmacogenomics Services Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Services as of 2025)
Table 11. Global Market Pharmacogenomics Services Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pharmacogenomics Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacogenomics Services Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pharmacogenomics Services Sales by Type (K Units)
Table 27. Global Pharmacogenomics Services Market Size by Type (M USD)
Table 28. Global Pharmacogenomics Services Sales (K Units) by Type (2020-2025)
Table 29. Global Pharmacogenomics Services Sales Market Share by Type (2020-2025)
Table 30. Global Pharmacogenomics Services Market Size (M USD) by Type (2020-2025)
Table 31. Global Pharmacogenomics Services Market Share by Type (2020-2025)
Table 32. Global Pharmacogenomics Services Price (USD/Unit) by Type (2020-2025)
Table 33. Global Pharmacogenomics Services Sales (K Units) by Application
Table 34. Global Pharmacogenomics Services Market Size by Application
Table 35. Global Pharmacogenomics Services Sales by Application (2020-2025) & (K Units)
Table 36. Global Pharmacogenomics Services Sales Market Share by Application (2020-2025)
Table 37. Global Pharmacogenomics Services Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pharmacogenomics Services Market Share by Application (2020-2025)
Table 39. Global Pharmacogenomics Services Sales Growth Rate by Application (2020-2025)
Table 40. Global Pharmacogenomics Services Sales by Region (2020-2025) & (K Units)
Table 41. Global Pharmacogenomics Services Sales Market Share by Region (2020-2025)
Table 42. Global Pharmacogenomics Services Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pharmacogenomics Services Market Size by Region (2020-2025)
Table 44. North America Pharmacogenomics Services Sales by Country (2020-2025) & (K Units)
Table 45. North America Pharmacogenomics Services Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pharmacogenomics Services Sales by Country (2020-2025) & (K Units)
Table 47. Europe Pharmacogenomics Services Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pharmacogenomics Services Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Pharmacogenomics Services Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pharmacogenomics Services Sales by Country (2020-2025) & (K Units)
Table 51. South America Pharmacogenomics Services Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pharmacogenomics Services Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Pharmacogenomics Services Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pharmacogenomics Services Production (K Units) by Region(2020-2025)
Table 55. Global Pharmacogenomics Services Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pharmacogenomics Services Revenue Market Share by Region (2020-2025)
Table 57. Global Pharmacogenomics Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Pharmacogenomics Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Pharmacogenomics Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Pharmacogenomics Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Pharmacogenomics Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Laboratories Basic Information
Table 63. Abbott Laboratories Pharmacogenomics Services Product Overview
Table 64. Abbott Laboratories Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories SWOT Analysis
Table 67. Abbott Laboratories Recent Developments
Table 68. Admera Health, LLC Basic Information
Table 69. Admera Health, LLC Pharmacogenomics Services Product Overview
Table 70. Admera Health, LLC Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Admera Health, LLC Business Overview
Table 72. Admera Health, LLC SWOT Analysis
Table 73. Admera Health, LLC Recent Developments
Table 74. Mesa Laboratories, Inc. Basic Information
Table 75. Mesa Laboratories, Inc. Pharmacogenomics Services Product Overview
Table 76. Mesa Laboratories, Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Mesa Laboratories, Inc. Business Overview
Table 78. Mesa Laboratories, Inc. SWOT Analysis
Table 79. Mesa Laboratories, Inc. Recent Developments
Table 80. Dynamic DNA Laboratories Basic Information
Table 81. Dynamic DNA Laboratories Pharmacogenomics Services Product Overview
Table 82. Dynamic DNA Laboratories Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Dynamic DNA Laboratories Business Overview
Table 84. Dynamic DNA Laboratories Recent Developments
Table 85. F. Hoffmann-La Roche Ltd. Basic Information
Table 86. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Overview
Table 87. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. F. Hoffmann-La Roche Ltd. Business Overview
Table 89. F. Hoffmann-La Roche Ltd. Recent Developments
Table 90. GeneOmbio Technologies Pvt Ltd. Basic Information
Table 91. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Overview
Table 92. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. GeneOmbio Technologies Pvt Ltd. Business Overview
Table 94. GeneOmbio Technologies Pvt Ltd. Recent Developments
Table 95. Exact Sciences Corporation Basic Information
Table 96. Exact Sciences Corporation Pharmacogenomics Services Product Overview
Table 97. Exact Sciences Corporation Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Exact Sciences Corporation Business Overview
Table 99. Exact Sciences Corporation Recent Developments
Table 100. Illumina, Inc. Basic Information
Table 101. Illumina, Inc. Pharmacogenomics Services Product Overview
Table 102. Illumina, Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Illumina, Inc. Business Overview
Table 104. Illumina, Inc. Recent Developments
Table 105. Laboratory Corporation of America Holdings Basic Information
Table 106. Laboratory Corporation of America Holdings Pharmacogenomics Services Product Overview
Table 107. Laboratory Corporation of America Holdings Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Laboratory Corporation of America Holdings Business Overview
Table 109. Laboratory Corporation of America Holdings Recent Developments
Table 110. Myriad Genetics, Inc. Basic Information
Table 111. Myriad Genetics, Inc. Pharmacogenomics Services Product Overview
Table 112. Myriad Genetics, Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Myriad Genetics, Inc. Business Overview
Table 114. Myriad Genetics, Inc. Recent Developments
Table 115. OmeCare Basic Information
Table 116. OmeCare Pharmacogenomics Services Product Overview
Table 117. OmeCare Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. OmeCare Business Overview
Table 119. OmeCare Recent Developments
Table 120. QIAGEN N.V. Basic Information
Table 121. QIAGEN N.V. Pharmacogenomics Services Product Overview
Table 122. QIAGEN N.V. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. QIAGEN N.V. Business Overview
Table 124. QIAGEN N.V. Recent Developments
Table 125. Quest Diagnostics Incorporated Basic Information
Table 126. Quest Diagnostics Incorporated Pharmacogenomics Services Product Overview
Table 127. Quest Diagnostics Incorporated Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Quest Diagnostics Incorporated Business Overview
Table 129. Quest Diagnostics Incorporated Recent Developments
Table 130. Thermo Fisher Scientific Inc. Basic Information
Table 131. Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Overview
Table 132. Thermo Fisher Scientific Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Thermo Fisher Scientific Inc. Business Overview
Table 134. Thermo Fisher Scientific Inc. Recent Developments
Table 135. Precipio Basic Information
Table 136. Precipio Pharmacogenomics Services Product Overview
Table 137. Precipio Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Precipio Business Overview
Table 139. Precipio Recent Developments
Table 140. 23andMe, Inc. Basic Information
Table 141. 23andMe, Inc. Pharmacogenomics Services Product Overview
Table 142. 23andMe, Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. 23andMe, Inc. Business Overview
Table 144. 23andMe, Inc. Recent Developments
Table 145. OneOme, LLC Basic Information
Table 146. OneOme, LLC Pharmacogenomics Services Product Overview
Table 147. OneOme, LLC Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. OneOme, LLC Business Overview
Table 149. OneOme, LLC Recent Developments
Table 150. DiaCarta, Inc. Basic Information
Table 151. DiaCarta, Inc. Pharmacogenomics Services Product Overview
Table 152. DiaCarta, Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. DiaCarta, Inc. Business Overview
Table 154. DiaCarta, Inc. Recent Developments
Table 155. OPKO Health Basic Information
Table 156. OPKO Health Pharmacogenomics Services Product Overview
Table 157. OPKO Health Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. OPKO Health Business Overview
Table 159. OPKO Health Recent Developments
Table 160. Global Pharmacogenomics Services Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Pharmacogenomics Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Pharmacogenomics Services Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Pharmacogenomics Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Pharmacogenomics Services Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Pharmacogenomics Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Pharmacogenomics Services Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Pharmacogenomics Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Pharmacogenomics Services Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Pharmacogenomics Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Pharmacogenomics Services Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Pharmacogenomics Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Pharmacogenomics Services Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Pharmacogenomics Services Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Pharmacogenomics Services Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Pharmacogenomics Services Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Pharmacogenomics Services Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pharmacogenomics Services Market Size by Type (M USD)
Table 4. Global Pharmacogenomics Services Market Size by Application
Table 5. Pharmacogenomics Services Market Size Comparison by Region (M USD)
Table 6. Global Pharmacogenomics Services Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Pharmacogenomics Services Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pharmacogenomics Services Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pharmacogenomics Services Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Services as of 2025)
Table 11. Global Market Pharmacogenomics Services Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Pharmacogenomics Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacogenomics Services Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pharmacogenomics Services Sales by Type (K Units)
Table 27. Global Pharmacogenomics Services Market Size by Type (M USD)
Table 28. Global Pharmacogenomics Services Sales (K Units) by Type (2020-2025)
Table 29. Global Pharmacogenomics Services Sales Market Share by Type (2020-2025)
Table 30. Global Pharmacogenomics Services Market Size (M USD) by Type (2020-2025)
Table 31. Global Pharmacogenomics Services Market Share by Type (2020-2025)
Table 32. Global Pharmacogenomics Services Price (USD/Unit) by Type (2020-2025)
Table 33. Global Pharmacogenomics Services Sales (K Units) by Application
Table 34. Global Pharmacogenomics Services Market Size by Application
Table 35. Global Pharmacogenomics Services Sales by Application (2020-2025) & (K Units)
Table 36. Global Pharmacogenomics Services Sales Market Share by Application (2020-2025)
Table 37. Global Pharmacogenomics Services Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pharmacogenomics Services Market Share by Application (2020-2025)
Table 39. Global Pharmacogenomics Services Sales Growth Rate by Application (2020-2025)
Table 40. Global Pharmacogenomics Services Sales by Region (2020-2025) & (K Units)
Table 41. Global Pharmacogenomics Services Sales Market Share by Region (2020-2025)
Table 42. Global Pharmacogenomics Services Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pharmacogenomics Services Market Size by Region (2020-2025)
Table 44. North America Pharmacogenomics Services Sales by Country (2020-2025) & (K Units)
Table 45. North America Pharmacogenomics Services Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pharmacogenomics Services Sales by Country (2020-2025) & (K Units)
Table 47. Europe Pharmacogenomics Services Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pharmacogenomics Services Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Pharmacogenomics Services Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pharmacogenomics Services Sales by Country (2020-2025) & (K Units)
Table 51. South America Pharmacogenomics Services Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pharmacogenomics Services Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Pharmacogenomics Services Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pharmacogenomics Services Production (K Units) by Region(2020-2025)
Table 55. Global Pharmacogenomics Services Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pharmacogenomics Services Revenue Market Share by Region (2020-2025)
Table 57. Global Pharmacogenomics Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Pharmacogenomics Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Pharmacogenomics Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Pharmacogenomics Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Pharmacogenomics Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Laboratories Basic Information
Table 63. Abbott Laboratories Pharmacogenomics Services Product Overview
Table 64. Abbott Laboratories Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories SWOT Analysis
Table 67. Abbott Laboratories Recent Developments
Table 68. Admera Health, LLC Basic Information
Table 69. Admera Health, LLC Pharmacogenomics Services Product Overview
Table 70. Admera Health, LLC Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Admera Health, LLC Business Overview
Table 72. Admera Health, LLC SWOT Analysis
Table 73. Admera Health, LLC Recent Developments
Table 74. Mesa Laboratories, Inc. Basic Information
Table 75. Mesa Laboratories, Inc. Pharmacogenomics Services Product Overview
Table 76. Mesa Laboratories, Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Mesa Laboratories, Inc. Business Overview
Table 78. Mesa Laboratories, Inc. SWOT Analysis
Table 79. Mesa Laboratories, Inc. Recent Developments
Table 80. Dynamic DNA Laboratories Basic Information
Table 81. Dynamic DNA Laboratories Pharmacogenomics Services Product Overview
Table 82. Dynamic DNA Laboratories Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Dynamic DNA Laboratories Business Overview
Table 84. Dynamic DNA Laboratories Recent Developments
Table 85. F. Hoffmann-La Roche Ltd. Basic Information
Table 86. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Product Overview
Table 87. F. Hoffmann-La Roche Ltd. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. F. Hoffmann-La Roche Ltd. Business Overview
Table 89. F. Hoffmann-La Roche Ltd. Recent Developments
Table 90. GeneOmbio Technologies Pvt Ltd. Basic Information
Table 91. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Product Overview
Table 92. GeneOmbio Technologies Pvt Ltd. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. GeneOmbio Technologies Pvt Ltd. Business Overview
Table 94. GeneOmbio Technologies Pvt Ltd. Recent Developments
Table 95. Exact Sciences Corporation Basic Information
Table 96. Exact Sciences Corporation Pharmacogenomics Services Product Overview
Table 97. Exact Sciences Corporation Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Exact Sciences Corporation Business Overview
Table 99. Exact Sciences Corporation Recent Developments
Table 100. Illumina, Inc. Basic Information
Table 101. Illumina, Inc. Pharmacogenomics Services Product Overview
Table 102. Illumina, Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Illumina, Inc. Business Overview
Table 104. Illumina, Inc. Recent Developments
Table 105. Laboratory Corporation of America Holdings Basic Information
Table 106. Laboratory Corporation of America Holdings Pharmacogenomics Services Product Overview
Table 107. Laboratory Corporation of America Holdings Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Laboratory Corporation of America Holdings Business Overview
Table 109. Laboratory Corporation of America Holdings Recent Developments
Table 110. Myriad Genetics, Inc. Basic Information
Table 111. Myriad Genetics, Inc. Pharmacogenomics Services Product Overview
Table 112. Myriad Genetics, Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Myriad Genetics, Inc. Business Overview
Table 114. Myriad Genetics, Inc. Recent Developments
Table 115. OmeCare Basic Information
Table 116. OmeCare Pharmacogenomics Services Product Overview
Table 117. OmeCare Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. OmeCare Business Overview
Table 119. OmeCare Recent Developments
Table 120. QIAGEN N.V. Basic Information
Table 121. QIAGEN N.V. Pharmacogenomics Services Product Overview
Table 122. QIAGEN N.V. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. QIAGEN N.V. Business Overview
Table 124. QIAGEN N.V. Recent Developments
Table 125. Quest Diagnostics Incorporated Basic Information
Table 126. Quest Diagnostics Incorporated Pharmacogenomics Services Product Overview
Table 127. Quest Diagnostics Incorporated Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Quest Diagnostics Incorporated Business Overview
Table 129. Quest Diagnostics Incorporated Recent Developments
Table 130. Thermo Fisher Scientific Inc. Basic Information
Table 131. Thermo Fisher Scientific Inc. Pharmacogenomics Services Product Overview
Table 132. Thermo Fisher Scientific Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Thermo Fisher Scientific Inc. Business Overview
Table 134. Thermo Fisher Scientific Inc. Recent Developments
Table 135. Precipio Basic Information
Table 136. Precipio Pharmacogenomics Services Product Overview
Table 137. Precipio Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Precipio Business Overview
Table 139. Precipio Recent Developments
Table 140. 23andMe, Inc. Basic Information
Table 141. 23andMe, Inc. Pharmacogenomics Services Product Overview
Table 142. 23andMe, Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. 23andMe, Inc. Business Overview
Table 144. 23andMe, Inc. Recent Developments
Table 145. OneOme, LLC Basic Information
Table 146. OneOme, LLC Pharmacogenomics Services Product Overview
Table 147. OneOme, LLC Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. OneOme, LLC Business Overview
Table 149. OneOme, LLC Recent Developments
Table 150. DiaCarta, Inc. Basic Information
Table 151. DiaCarta, Inc. Pharmacogenomics Services Product Overview
Table 152. DiaCarta, Inc. Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. DiaCarta, Inc. Business Overview
Table 154. DiaCarta, Inc. Recent Developments
Table 155. OPKO Health Basic Information
Table 156. OPKO Health Pharmacogenomics Services Product Overview
Table 157. OPKO Health Pharmacogenomics Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. OPKO Health Business Overview
Table 159. OPKO Health Recent Developments
Table 160. Global Pharmacogenomics Services Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Pharmacogenomics Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Pharmacogenomics Services Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Pharmacogenomics Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Pharmacogenomics Services Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Pharmacogenomics Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Pharmacogenomics Services Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Pharmacogenomics Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Pharmacogenomics Services Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Pharmacogenomics Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Pharmacogenomics Services Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Pharmacogenomics Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Pharmacogenomics Services Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Pharmacogenomics Services Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Pharmacogenomics Services Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Pharmacogenomics Services Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Pharmacogenomics Services Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pharmacogenomics Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacogenomics Services Market Size (M USD), 2025-2035
Figure 5. Global Pharmacogenomics Services Market Size (M USD) (2020-2035)
Figure 6. Global Pharmacogenomics Services Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacogenomics Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pharmacogenomics Services Product Life Cycle
Figure 13. Pharmacogenomics Services Sales Share by Manufacturers in 2025
Figure 14. Global Pharmacogenomics Services Revenue Share by Manufacturers in 2025
Figure 15. Pharmacogenomics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pharmacogenomics Services Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pharmacogenomics Services Revenue in 2025
Figure 18. Industry Chain Map of Pharmacogenomics Services
Figure 19. Global Pharmacogenomics Services Market PEST Analysis
Figure 20. Global Pharmacogenomics Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pharmacogenomics Services Market Share by Type
Figure 27. Sales Market Share of Pharmacogenomics Services by Type (2020-2025)
Figure 28. Sales Market Share of Pharmacogenomics Services by Type in 2025
Figure 29. Market Share of Pharmacogenomics Services by Type (2020-2025)
Figure 30. Market Share of Pharmacogenomics Services by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pharmacogenomics Services Market Share by Application
Figure 33. Global Pharmacogenomics Services Sales Market Share by Application (2020-2025)
Figure 34. Global Pharmacogenomics Services Sales Market Share by Application in 2025
Figure 35. Global Pharmacogenomics Services Market Share by Application (2020-2025)
Figure 36. Global Pharmacogenomics Services Market Share by Application in 2025
Figure 37. Global Pharmacogenomics Services Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pharmacogenomics Services Sales Market Share by Region (2020-2025)
Figure 39. Global Pharmacogenomics Services Market Size by Region (2020-2025)
Figure 40. North America Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Pharmacogenomics Services Sales Market Share by Country in 2024
Figure 43. North America Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pharmacogenomics Services Market Size by Country in 2024
Figure 45. U.S. Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pharmacogenomics Services Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Pharmacogenomics Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pharmacogenomics Services Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pharmacogenomics Services Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Pharmacogenomics Services Sales Market Share by Country in 2024
Figure 53. Europe Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pharmacogenomics Services Market Size by Country in 2024
Figure 55. Germany Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pharmacogenomics Services Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Pharmacogenomics Services Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pharmacogenomics Services Market Size by Region in 2024
Figure 68. China Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pharmacogenomics Services Sales and Growth Rate (K Units)
Figure 79. South America Pharmacogenomics Services Sales Market Share by Country in 2024
Figure 80. South America Pharmacogenomics Services Market Size and Growth Rate (M USD)
Figure 81. South America Pharmacogenomics Services Market Size by Country in 2024
Figure 82. Brazil Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pharmacogenomics Services Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Pharmacogenomics Services Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pharmacogenomics Services Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pharmacogenomics Services Market Size by Region in 2024
Figure 92. Saudi Arabia Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pharmacogenomics Services Production Market Share by Region (2020-2025)
Figure 103. North America Pharmacogenomics Services Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Pharmacogenomics Services Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Pharmacogenomics Services Production (K Units) Growth Rate (2020-2025)
Figure 106. China Pharmacogenomics Services Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Pharmacogenomics Services Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Pharmacogenomics Services Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pharmacogenomics Services Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pharmacogenomics Services Market Share Forecast by Type (2026-2035)
Figure 111. Global Pharmacogenomics Services Sales Forecast by Application (2026-2035)
Figure 112. Global Pharmacogenomics Services Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Pharmacogenomics Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacogenomics Services Market Size (M USD), 2025-2035
Figure 5. Global Pharmacogenomics Services Market Size (M USD) (2020-2035)
Figure 6. Global Pharmacogenomics Services Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacogenomics Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pharmacogenomics Services Product Life Cycle
Figure 13. Pharmacogenomics Services Sales Share by Manufacturers in 2025
Figure 14. Global Pharmacogenomics Services Revenue Share by Manufacturers in 2025
Figure 15. Pharmacogenomics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pharmacogenomics Services Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pharmacogenomics Services Revenue in 2025
Figure 18. Industry Chain Map of Pharmacogenomics Services
Figure 19. Global Pharmacogenomics Services Market PEST Analysis
Figure 20. Global Pharmacogenomics Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pharmacogenomics Services Market Share by Type
Figure 27. Sales Market Share of Pharmacogenomics Services by Type (2020-2025)
Figure 28. Sales Market Share of Pharmacogenomics Services by Type in 2025
Figure 29. Market Share of Pharmacogenomics Services by Type (2020-2025)
Figure 30. Market Share of Pharmacogenomics Services by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pharmacogenomics Services Market Share by Application
Figure 33. Global Pharmacogenomics Services Sales Market Share by Application (2020-2025)
Figure 34. Global Pharmacogenomics Services Sales Market Share by Application in 2025
Figure 35. Global Pharmacogenomics Services Market Share by Application (2020-2025)
Figure 36. Global Pharmacogenomics Services Market Share by Application in 2025
Figure 37. Global Pharmacogenomics Services Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pharmacogenomics Services Sales Market Share by Region (2020-2025)
Figure 39. Global Pharmacogenomics Services Market Size by Region (2020-2025)
Figure 40. North America Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Pharmacogenomics Services Sales Market Share by Country in 2024
Figure 43. North America Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pharmacogenomics Services Market Size by Country in 2024
Figure 45. U.S. Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pharmacogenomics Services Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Pharmacogenomics Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pharmacogenomics Services Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pharmacogenomics Services Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Pharmacogenomics Services Sales Market Share by Country in 2024
Figure 53. Europe Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pharmacogenomics Services Market Size by Country in 2024
Figure 55. Germany Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pharmacogenomics Services Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Pharmacogenomics Services Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pharmacogenomics Services Market Size by Region in 2024
Figure 68. China Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pharmacogenomics Services Sales and Growth Rate (K Units)
Figure 79. South America Pharmacogenomics Services Sales Market Share by Country in 2024
Figure 80. South America Pharmacogenomics Services Market Size and Growth Rate (M USD)
Figure 81. South America Pharmacogenomics Services Market Size by Country in 2024
Figure 82. Brazil Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pharmacogenomics Services Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Pharmacogenomics Services Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pharmacogenomics Services Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pharmacogenomics Services Market Size by Region in 2024
Figure 92. Saudi Arabia Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pharmacogenomics Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Pharmacogenomics Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pharmacogenomics Services Production Market Share by Region (2020-2025)
Figure 103. North America Pharmacogenomics Services Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Pharmacogenomics Services Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Pharmacogenomics Services Production (K Units) Growth Rate (2020-2025)
Figure 106. China Pharmacogenomics Services Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Pharmacogenomics Services Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Pharmacogenomics Services Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pharmacogenomics Services Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pharmacogenomics Services Market Share Forecast by Type (2026-2035)
Figure 111. Global Pharmacogenomics Services Sales Forecast by Application (2026-2035)
Figure 112. Global Pharmacogenomics Services Market Share Forecast by Application (2026-2035)
